-
Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald
Source: Buzz FX / 01 Feb 2025 06:11:10 America/New_York
Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald Written by MarketBeat February 1, 2025 Share Link copied to clipboard. Aclaris Therapeutics ( NASDAQ:ACRS - Get Free Report ) was upgraded by analysts at
Read more...